BODI
The Beachbody Company, Inc.
BODI's fundamentals are mixed: its operating margin went from −13% to 7%, but revenue fell 28%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
BODI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
BODI's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
BODI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.1x | $3.25 | — |
| Cheap | 2.6x | $4.11 | +27% |
| Fair | 4.1x | $6.41 | +97% |
| Expensive | 15x | $22.97 | +607% |
Historical ranges are pointers, not guarantees.
BODI has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
BODI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect BODI's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
BODI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.56 | +$7.81 |
| Q2 2026 | $1.69 | +$10.20 |
| Q1 2026 | $0.73 | +$9.98 |
| Q4 2025 | -$0.41 | +$10.10 |
| Q3 2025 | -$6.25 | +$9.66 |
| Q2 2025 | -$8.51 | +$11.15 |
| Q1 2025 | -$9.25 | +$12.82 |
| Q4 2024 | -$10.51 | +$13.96 |
BODI has returned to profit: it earned $1.56 per share over the past year, after losing money the year before.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over BODI in the latest year-over-year earnings comparison.
BODI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.2M | -25% |
| Q2 2026 | $49.6M | -22% |
| Q1 2026 | $54.3M | -25% |
| Q4 2025 | $55.5M | -36% |
| Q3 2025 | $59.9M | -41% |
| Q2 2025 | $63.9M | -42% |
| Q1 2025 | $72.4M | -40% |
| Q4 2024 | $86.4M | -27% |
BODI has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -5.4 points |
| Q2 2026 | 3.4% | +9.6 points |
| Q1 2026 | 5.7% | +11 points |
| Q4 2025 | 15% | +53 points |
| Q3 2025 | 8.3% | +21 points |
| Q2 2025 | -6.2% | +2.4 points |
| Q1 2025 | -5.1% | +3.9 points |
| Q4 2024 | -38% | +13 points |
BODI's operating margin was 2.9% last quarter, down 5.4 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
BODI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | -171% |
| Q2 2026 | -$4M | -265% |
| Q1 2026 | -$1.7M | -205% |
| Q4 2025 | $4.3M | +$11.6M |
| Q3 2025 | $9M | +16881% |
| Q2 2025 | $2.4M | +$4.6M |
| Q1 2025 | $1.6M | -78% |
| Q4 2024 | -$7.3M | +$1.7M |
BODI has burned cash in most quarters: −$8M over the past year, against $6M the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
BODI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.2% | -487K shares |
| 1 year | +5.3% | +372K shares |
| 3 years | +20% | +1.2M shares |
| 5 years | +22% | +1.3M shares |
BODI has 7M diluted shares, up 5.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over BODI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
BODI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2020 | -1.0x | Net Cash |
BODI has more cash than debt.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
BODI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 2.2 | Oversold |
BODI's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
BODI PE vs Communication Services Sector
| Metric | BODI | Sector median | Relative |
|---|---|---|---|
| PE | 2.1x | 16x | 87% below |
| PE % | 0 | 28 | 28 pts below |
BODI has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
BODI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 25% below |
| 20 week MA | $6.65 | 51% below |
| 50 week MA | $9.06 | 64% below |
| 100 week MA | $7.32 | 56% below |
| 200 week MA | $10.8 | 70% below |
NBIS has stronger trend alignment. BODI is above 0 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
BODI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $523.5 | $126.0 | -76% |
| 2022 | $126.0 | $27.3 | -78% |
| 2023 | $27.3 | $8.29 | -70% |
| 2024 | $8.29 | $6.07 | -27% |
| 2025 | $6.07 | $10.1 | +66% |
| 2026 YTD | $10.1 | $3.25 | -68% |
BODI has finished lower in four of the last five years. It's down 68% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over BODI on returns for 2026, with the stronger performance.